| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| framycetin sulfate~dexamethasone~gramicidin | Ear Drops | 5 mg/mL~.5 mg/mL~.05 mg/mL | Current | Limited Availability | Manufacturing | 7/06/2024 |
| sodium fluoride | Injection, concentrated | 1 mg/mL | Current | Limited Availability | Manufacturing | 7/06/2024 |
| olanzapine | Tablet, film coated | 7.5 mg | Current | Unavailable | Manufacturing | 7/06/2024 |
| vincristine sulfate | Injection, solution | 1 mg/mL | Anticipated | Available | Manufacturing | 7/06/2024 |
| ethinylestradiol~drospirenone | Tablet | 30 microgram~3 mg | Anticipated | Available | Manufacturing | 7/06/2024 |
| carmustine | Injection, powder for | 100 mg | Anticipated | Available | Manufacturing | 7/06/2024 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, multilayer | 21.7 mg~10 mg | Current | Unavailable | Manufacturing | 7/06/2024 |
| pemetrexed disodium | Injection, powder for | 1102.9 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 7/06/2024 |
| desvenlafaxine benzoate | Tablet, modified release | 73.16 mg | Anticipated | Available | Manufacturing | 7/06/2024 |
| clindamycin phosphate~tretinoin | Gel | 12 mg~.25 mg | Resolved | Available | Manufacturing | 7/06/2024 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 12.5 mg~150 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/06/2024 |
| amlodipine besilate~olmesartan medoxomil | Tablet, film coated | 6.935 mg~40 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 7/06/2024 |
| bortezomib | Injection, powder for | 3.5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/06/2024 |
| mercaptopurine monohydrate | Tablet | 50 mg | Current | Limited Availability | Manufacturing | 7/06/2024 |
| ezetimibe~atorvastatin calcium trihydrate | Tablet, film coated | 10 mg~41.363 mg | Anticipated | Available | Manufacturing | 7/06/2024 |
| prasugrel | Tablet, film coated | 5 mg | Anticipated | Available | Manufacturing | 7/06/2024 |
| thiotepa | Injection, powder for | 100 mg | Current | Unavailable | Commercial Changes / Commercial viability | 7/06/2024 |
| oxycodone hydrochloride | Capsule, hard | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 7/06/2024 |
| famotidine | Tablet, film coated | 40 mg | Current | Limited Availability | Manufacturing | 7/06/2024 |
| acetylcholine chloride | Solution, powder for irrigation | 10 mg/mL | Current | Unavailable | Manufacturing | 6/06/2024 |
| adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride | Injection, solution | 9.1 microgram/mL~20 mg/mL | Resolved | Available | Manufacturing | 6/06/2024 |
| hydroxocobalamin chloride | Injection, solution | 1.027 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 6/06/2024 |
| insulin | Injection, solution | 100 IU/mL | Current | Limited Availability | Manufacturing | 6/06/2024 |
| methotrexate | Injection, solution | 2.5 mg/mL | Current | Limited Availability | Manufacturing | 6/06/2024 |
| betamethasone acetate~betamethasone sodium phosphate | Injection, suspension | 3 mg/mL~3.9 mg/mL | Current | Limited Availability | Product recall | 6/06/2024 |
| quetiapine fumarate | Tablet, film coated | 28.78 mg | Current | Unavailable | Manufacturing | 6/06/2024 |
| enoxaparin sodium | Injection, solution | 60 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 6/06/2024 |
| arginine hydrochloride | Injection, intravenous infusion | 600 mg/mL | Resolved | Available | Manufacturing | 6/06/2024 |
| Insulin degludec~Insulin aspart | Injection, solution | 420 nmol/mL~180 nmol/mL | Current | Limited Availability | Manufacturing | 6/06/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 6/06/2024 |
| lidocaine hydrochloride | Injection, solution | 400 mg | Current | Unavailable | Manufacturing | 6/06/2024 |
| octreotide | Injection, modified release | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 6/06/2024 |
| octreotide | Injection, modified release | 30 mg | Discontinued | Unavailable | Manufacturing | 6/06/2024 |
| octreotide | Injection, modified release | 20 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 6/06/2024 |
| levodopa~carbidopa monohydrate | Tablet, modified release | 200 mg~54 mg | Anticipated | Available | Manufacturing | 6/06/2024 |
| estradiol | Drug delivery system, transdermal | .78 mg | Current | Limited Availability | Manufacturing | 6/06/2024 |
| cabazitaxel | Injection, concentrated | 60 mg | Resolved | Available | Manufacturing | 6/06/2024 |
| amlodipine besilate~olmesartan medoxomil | Tablet, film coated | 6.94 mg~40 mg | Current | Limited Availability | Unexpected increase in consumer demand | 6/06/2024 |
| bortezomib | Injection, powder for | 3.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 6/06/2024 |
| naproxen | Tablet, uncoated | 250 mg | Current | Unavailable | Manufacturing | 6/06/2024 |
| diltiazem hydrochloride | Capsule, modified release | 240 mg | Resolved | Available | Manufacturing | 6/06/2024 |
| sodium oxidronate | Injection, powder for | 3.15 mg | Current | Unavailable | Manufacturing | 6/06/2024 |
| ganciclovir sodium | Injection, powder for | 543 mg | Current | Limited Availability | Manufacturing | 5/06/2024 |
| hydrochlorothiazide~enalapril maleate | Tablet, uncoated | 6 mg~20 mg | Resolved | Available | Manufacturing | 5/06/2024 |
| isoniazid | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 5/06/2024 |
| sodium pyrophosphate | Injection, powder for | 30 mg | Current | Unavailable | Manufacturing | 5/06/2024 |
| midazolam | Injection, solution | 5 mg | Anticipated | Available | Manufacturing | 5/06/2024 |
| hydrochlorothiazide~telmisartan | Tablet, film coated | 12.5 mg~80 mg | Current | Unavailable | Manufacturing | 5/06/2024 |
| metformin hydrochloride | Tablet, modified release | 1000 mg | Current | Limited Availability | Manufacturing | 5/06/2024 |
| entecavir | Tablet, film coated | 1 mg | Resolved | Available | Manufacturing | 5/06/2024 |
| Insulin aspart | Injection, solution | 100 U/mL | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 5/06/2024 |
| oxycodone hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 5/06/2024 |
| ganciclovir sodium | Injection, powder for | 546 mg | Anticipated | Available | Manufacturing | 5/06/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 5/06/2024 |
| cisplatin | Injection, concentrated | 1 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 5/06/2024 |
| cisplatin | Injection, concentrated | 1 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 5/06/2024 |
| dasatinib | Tablet, film coated | 50 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 5/06/2024 |
| latanoprost | Eye Drops, solution | .05 mg/mL | Current | Unavailable | Manufacturing | 5/06/2024 |
| timolol maleate~latanoprost | Eye Drops, solution | 6.83 mg/mL~.05 mg/mL | Resolved | Available | Manufacturing | 5/06/2024 |
| lacosamide | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 5/06/2024 |
| gliclazide | Tablet, modified release | 30 mg | Current | Unavailable | Manufacturing | 5/06/2024 |
| acalabrutinib | Capsule, hard | 100 mg | Discontinued | Unavailable | Transport / Logistic issues / Storage capacity issues | 5/06/2024 |
| medroxyprogesterone acetate | Tablet, uncoated | 10 mg | Resolved | Available | Manufacturing | 5/06/2024 |
| cisplatin | Injection, solution | 1 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 5/06/2024 |
| tretinoin | Capsule, soft | 10 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 5/06/2024 |
| clarithromycin | Oral Liquid, powder for | 50 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 5/06/2024 |
| ketamine hydrochloride | Injection, solution | 115.3 mg/mL | Current | Limited Availability | Manufacturing | 5/06/2024 |
| diltiazem hydrochloride | Tablet, film coated | 60 mg | Anticipated | Available | Manufacturing | 5/06/2024 |
| famotidine | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 5/06/2024 |
| Coxiella burnetii | Injection | 50 microgram/mL | Current | Limited Availability | Manufacturing | 4/06/2024 |
| Coxiella burnetii | Injection | 5 microgram/mL | Current | Limited Availability | Manufacturing | 4/06/2024 |
| lisinopril dihydrate | Tablet, uncoated | 10.89 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 4/06/2024 |
| fludarabine phosphate | Injection, concentrated | 50 mg | Current | Unavailable | Manufacturing | 4/06/2024 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Resolved | Available | Unexpected increase in consumer demand | 4/06/2024 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 4/06/2024 |
| candesartan cilexetil~hydrochlorothiazide | Tablet, uncoated | 32 mg~25 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 4/06/2024 |
| ziprasidone hydrochloride | Capsule, hard | 65.16 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 4/06/2024 |
| aciclovir sodium dihydrate | Injection, powder for | 628.8 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 4/06/2024 |
| mesalazine | Tablet, enteric coated | 800 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 4/06/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 4/06/2024 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Limited Availability | Manufacturing | 4/06/2024 |
| carbetocin | Injection, solution | 100 microgram | Resolved | Available | Manufacturing | 4/06/2024 |
| tazobactam sodium~piperacillin sodium | Injection, powder for | 536.6 mg~4.17 g | Resolved | Available | Manufacturing | 4/06/2024 |
| isotretinoin | Capsule, soft | 20 mg | Resolved | Available | Manufacturing | 4/06/2024 |
| bendamustine hydrochloride monohydrate | Injection, powder for | 25 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 4/06/2024 |
| rifampicin | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 4/06/2024 |
| rifampicin | Capsule, hard | 300 mg | Current | Limited Availability | Manufacturing | 4/06/2024 |
| lidocaine hydrochloride monohydrate | Injection, solution | 20 mg/mL | Anticipated | Available | Manufacturing | 4/06/2024 |
| Insulin lispro | Injection, solution | 100 IU/mL | Current | Limited Availability | Manufacturing | 4/06/2024 |
| raltitrexed | Injection, powder for | 2 mg | Anticipated | Available | Unexpected increase in consumer demand | 4/06/2024 |
| desonide | Lotion | .5 mg/g | Current | Limited Availability | Manufacturing | 4/06/2024 |
| midazolam | Injection, solution | 5 mg/mL | Current | Limited Availability | Manufacturing | 4/06/2024 |
| tobramycin | Inhalation, conventional | 60 mg/mL | Current | Unavailable | Manufacturing | 4/06/2024 |
| gliclazide | Tablet, modified release | 30 mg | Current | Limited Availability | Manufacturing | 3/06/2024 |
| lercanidipine hydrochloride | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 3/06/2024 |
| duloxetine hydrochloride | Capsule, enteric | 33.65 mg | Current | Unavailable | Manufacturing | 3/06/2024 |
| cinacalcet hydrochloride | Tablet | 99.191 mg | Current | Limited Availability | Manufacturing | 3/06/2024 |
2024年6月10日